Literature DB >> 23036907

LC-MS analysis of glycopeptides of recombinant monoclonal antibodies by a rapid digestion procedure.

Yi Du1, Fengqiang Wang, Kimberly May, Wei Xu, Hongcheng Liu.   

Abstract

N-glycan analysis of recombinant monoclonal antibodies (mAbs) usually requires the removal of oligosaccharides by PNGase F followed by 2-AB labeling, normal phase high performance liquid chromatography (NP-HPLC) separation and fluorescence detection. Alternatively antibodies can be completely digested by trypsin to generate glycopeptides for analysis by liquid chromatography-mass spectrometry (LC-MS). Here, we report the development of a rapid digestion procedure to generate glycopeptides for quantitative LC-MS analysis. Recombinant monoclonal antibodies were digested using a combination of Lys-C and trypsin at 37°C for 15 min. The glycan profiles from this rapid digestion procedure are in good agreement with those from LC-MS analysis of glycopeptides from completely digested antibodies and those from NP-HPLC analysis of 2-AB labeled PNGase F released oligosaccharides. This rapid digestion procedure was applied to the comparison of oligosaccharides of two different antibodies. Glycopeptides from the two antibodies were differentially labeled with stable isotopes and analyzed simultaneously after a 1:1 mixing. The combination of the rapid digestion procedure and differential stable isotope labeling significantly reduced the turnaround time.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036907     DOI: 10.1016/j.jchromb.2012.09.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis.

Authors:  Yongle Pang; Wei-Han Wang; Gavin E Reid; Donald F Hunt; Merlin L Bruening
Journal:  Anal Chem       Date:  2015-10-22       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.